Chondroprotection
A chondroprotective compound is a specific compound or chemical that delays progressive joint space narrowing characteristic of arthritis and improves the biomechanics of articular joints by protecting chondrocytes.[1] These agents perform various functions, such as:
- Stimulating chondrocyte synthesis of collagen and proteoglycans
- Enhancing synoviocyte production of hyaluronan
- Inhibiting cartilage degradation
- Preventing fibrin formation in the vasculature
Chondroprotective agents can include both endogenous and synthetic chemicals. Endogenous molecules include hyaluronic acid, glucosamine, and chondroitin sulfate.[2]
References
- ↑ Felson, David T.; Kim, Young-Jo (2007). "The Futility of Current Approaches to Chondroprotection". Arthritis & Rheumatism. 56 (5): 1378–1383. doi:10.1002/art.22526.
- ↑ "Treating Osteoarthritis with Chondroprotective Agents". aboutjoints.com. Retrieved 2015-08-31.
This article is issued from Wikipedia - version of the 8/25/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.